Hedge Fund - Cormorant Asset Management
Prometheus Biosciences Inc. (RXDX)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q2 (2023-06-30) | $0 | 0% | 0 | $181.30 |
2 | 2023 - Q1 (2023-03-31) | $177,615 | 11.69% | 1,655,000 | $115.10 |
3 | 2022 - Q4 (2022-12-31) | $229,900 | 15.38% | 2,090,000 | $64.85 |
4 | 2022 - Q3 (2022-09-30) | $116,790,000 | 8.16% | 1,979,158 | $45.76 |
5 | 2022 - Q2 (2022-06-30) | $57,283,000 | 4.33% | 2,029,158 | $28.98 |
6 | 2022 - Q1 (2022-03-31) | $68,853,000 | 5.28% | 1,823,444 | $39.53 |
7 | 2021 - Q4 (2021-12-31) | $73,071,000 | 4.34% | 1,848,024 | $31.30 |
8 | 2021 - Q3 (2021-09-30) | $43,817,000 | 1.78% | 1,848,024 | $23.60 |
9 | 2021 - Q2 (2021-06-30) | $44,480,000 | 1.51% | 1,848,024 | $22.31 |
10 | 2021 - Q1 (2021-03-31) | $36,623,000 | 0.81% | 2,098,024 | $20.65 |
The displayed share prices are average quarterly stock market prices.